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Abstract
Background: Neisseria gonorrhoeae is an obligate human pathogen that causes significant
worldwide morbidity. N. gonorrhoeae expresses lipooligosaccharide (LOS), a phase variable
molecule that plays an important role during pathogenesis of the organism. Alteration in the
structure of gonococcal LOS correlates with altered disease presentation. In addition, LOS
sialylation occurs readily in vivo, though the role of this sialylation during disease is unknown.
Results: Challenge of human monocytes with purified LOS preparations isolated from strains
expressing distinct structurally defined LOSs resulted in identical production of the
proinflammatory cytokines tumor necrosis factor alpha (TNFα) and interleukin-12 (IL-12).
Similar results were seen when monocytes were challenged with either live or gentamicin-killed
whole cell gonococcal variants expressing these LOS structures, although greater cytokine
production was observed in comparison with challenge by purified LOS. Challenge of a human
primary monocyte model with distinct LOS variants resulted in similar production of TNFα, IL-
12, interleukin-10 (IL-10), and interleukin-8 (IL-8). A cytokine array was employed to allow
measurement of a broad range of cytokines in samples challenge with gonococcal LOS variants
as well as variants expressing sialylated LOS. Challenge of primary monocytes with sialylated
gonococci was shown to elicit the production of more MCP-2 (monocyte chemoattractant
protein-2) in comparison with challenge by unsialylated gonococci.
Conclusion: We demonstrated that while alterations in the carbohydrate moiety of LOS do
not impact the production of most cytokines by human monocytes, whole-cell bacterial
challenge is more stimulatory than challenge with purified LOS, implying that other gonococcal
cell surface antigens are important for the elicitation of cytokines. Challenge with gonococci
expressing sialylated LOS resulted in elicitation of more of the chemokine MCP-2 from
challenged cells in comparison with gonococci expressing unsialylated LOS. As MCP-2 is an
important chemoattractant, this indicates that in vivo sialylation may play an important role during
the pathogenesis of N. gonorrhoeae.
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Neisseria gonorrhoeae is an obligate human pathogen that
has an important global impact on human health. Signif-
icant disease sequelae can result from infection by N. gon-
orrhoeae, including pelvic inflammatory disease (PID),
which often results in sterility in women. This organism
employs several cell surface virulence factors, including
lipooligosaccharide (LOS), opacity-associated protein
(Opa), and pili, to initiate infection. N. gonorrhoeae
achieves colonization and invasion through a multi-step
process, presumably using multiple surface molecules,
and interacting with many types of host cells and host cell
receptors (For recent review, see [1]). Inflammation and
immune cell influx are two important diagnostic symp-
toms of gonorrhea.
Lipopolysaccharides (LPS) constitute a family of toxic gly-
colipids which are integral in the outer membranes of
gram-negative organisms. These molecules are critical for
the integrity and functioning of the outer membrane [2].
They are also important surface antigens and are highly
immunostimulatory. Systemic distribution of LPS can
lead to endotoxic shock [3]. In addition, variation in LPS
structure has been shown to affect bacterial virulence [4].
An LPS molecule generally consists of a highly hydropho-
bic Lipid A, a covalently attached core region (which can
be divided into an inner and outer core), and a polymer
of a repeating saccharide. The O-polysaccharide portion
of the molecule, however, is not ubiquitous. Several gram-
negative bacterial strains, such as N. gonorrhoeae, express a
glycolipid with a truncated, non-repeating oligosaccha-
ride chain, called LOS (see Fig. 1 for schematic of gono-
coccal LOS) [5]. The gonococcus variably expresses some
of the genes encoding the glycosyl transfersases needed for
LOS biosynthesis, and this results in rapid and reversible
alterations in the oligosaccharide structure [6]. A single
strain of N. gonorrhoeae (and even a single gonococcal
cell) can express several LOS structures at any given time
[7].
The role of gonococcal LOS has been shown by many
groups to be important in disease pathogenesis [8-10].
Harvey, et al. have demonstrated an important interaction
between those gonococci expressing lacto-N-neotetraose-
Schematic representation of the structure of LOS from N. gonorrhoeae strain F62Figure 1
Schematic representation of the structure of LOS from N. gonorrhoeae strain F62. LOS biosynthesis genes are indi-
cated by italics. Dotted lines indicate alternative LOS structures. Asterisks (*) indicate possible site of PEA or phosphate 
attachment. The broken line indicates the addition of an alternate α chain, joined to HepI as a β1-4 linkage (Figure modified 
from [48]).Page 2 of 15
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of primary human urethral epithelial cells [10]. Strains
expressing lacto-N-neotetraose-terminal LOS were signifi-
cantly more invasive than strains containing a deletion of
the terminal Galβ1-4 and subsequent sugars [11]. Song, et
al. demonstrated that in the absence of Opa proteins,
strains expressing a specific LOS (containing a terminal
lacto-N-neotetraose) promoted increased gonococcal
invasion of epithelial monolayers [9]. In addition, gono-
cocci expressing LOS with a predominantly specific carbo-
hydrate structure have been associated with either
symptomatology or a lack of symptoms in male clinical
trials, further supporting the observation of pathogenic
LOS phenotypes [8]. These studies demonstrated that
after inoculating volunteers with low-molecular weight
LOS variants, urethritis developed and primarily high
molecular weight LOS (terminal lacto-N-neotetraose) was
purified from the exudates. Thus, while the lipid A portion
of the LOS molecule has historically been designated the
immunogenic portion of the molecule, the carbohydrate
structures of LOS also play an important function in dis-
ease pathogenesis.
Sialylation of LOS also impacts gonococcal interactions
with host cells [12]. Sialylated strains have been shown to
be resistant to complement-mediated killing [13], to have
a decreased ability to induce oxidative burst in neu-
trophils[14], and to possess a decreased ability to adhere
to neutrophils in the absence of complement [15]. It has
also been observed that sialylation of gonococci in vitro
[by the addition of cytidine 5'-monophospho-N- acetyl-
neuraminic acid (CMP-NANA)] reduces their ability to
invade tissue culture epithelial cells [16]. At present, fur-
ther implications of LOS sialylation in the context of
molecular mimicry remain unclear, though this process
appears to be of significant biological importance. Since
certain gonococcal LOS structures (potentially able to be
sialylated) are associated with specific degrees of symp-
tomatology, it is possible that LOS structure is integral in
determining the severity of a gonococcal infection, and
may serve to contribute to bacterial evasion of the host
immune system.
Lipopolysaccharide (LPS) is known to be highly immu-
nostimulatory, and can elicit a variety of pro-inflamma-
tory cytokines and chemokines from host cells during
infection [17]. However, the immunostimulatory effects
of gonococcal LOS during infection remain somewhat
controversial. Several studies differ in their observations
regarding the types and amounts of cytokines elicited.
Some of these contradictions may stem from use of differ-
ent bacterial strains, phase variation of LOS molecules in
culture, and different cellular models of infection, possi-
bly resulting in different LOS receptor expression/density.
In addition, the biological significance of LOS antigenic
variation during infection has not been determined. In
general, it is accepted that the fallopian tube tissue dam-
age resulting from gonococcal infections can be attributed
to the cytokine tumor necrosis factor alpha (TNFα)
[18,19]. However, since epithelial cell-associated gono-
cocci have evolved a mechanism to protect the cells from
undergoing TNFα-mediated apoptosis [20], the role of
TNFα in damage to other reproductive mucosa is unclear.
In addition, interleukin-8 (IL-8), interleukin-6 (IL-6), and
interleukin-1 beta (IL-1β) have been measured following
gonococcal challenge of several models [21-25]. In vivo
studies are rare, but occasionally naturally occurring infec-
tions in women have been monitored. Gonococcal cervi-
citis in female sex workers has been shown to cause
increases in interleukin-4 (IL-4), IL-6, interleukin-10 (IL-
10), and TNFα, as well as a decline in CD4+ T cell counts
[26]. Though the importance of the cytokine IL-12 during
gonococcal infections remains to be determined, this
cytokine appears to be of significance during meningococ-
cal infections [27]. Cytokines such as TNF, IL-1β, IL-12,
IL-10, MCP-1 (monocyte chemoattractant protein-1), IL-
6, and RANTES (regulated upon activation, normal T-cell
expressed, and presumably secreted) have also been meas-
ured during challenge with meningococcal LOS [27-30].
However, the ability of monomeric peptidoglycan frag-
ments from N. gonorrhoeae to damage human fallopian-
tube mucosa has also been demonstrated [31]
Different LOS structures have been shown to correlate
with disease symptomatology: lacto-N-neotetraose LOS is
associated with symptomatic gonococcal infection, while
lactosyl LOS is associated with asymptomatic gonococcal
infection [8]. In this study, we tested whether these natu-
rally occurring LOS structures would differentially impact
cytokine production by human monocytes. We hypothe-
sized that compared with strains F62 and F62ΔlgtD
(expressing lacto-N-neotetraose LOS), strain F62ΔlgtA
(expressing lactosyl LOS) would elicit lower levels of the
cytokines associated with symptoms (such as TNFα). We
further hypothesized that this strain might elicit greater
production of IL-10, thereby suppressing pro-inflamma-
tory responses. The ability of purified LOS and isogenic
strains expressing two distinct LOS variants to elicit
cytokines was investigated. In addition, the effects of bac-
terial sialylation upon cytokine production were also
examined. We chose to focus on measurement of the
cytokines TNFα, IL-10, IL-12, and IL-8 due to both signif-
icance in published work and potential significance
regarding the overall disease model. In our studies, both a
human tissue culture cell model and a primary human cell
model were utilized.Page 3 of 15
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Challenge of THP-1 cells with equivalent amounts of LOS/
LPS from different variants results in similar production of 
TNFα and IL-12
In order to directly study the effects of LOS variation on
human monocytic cytokine production, THP-1 cells were
challenged with purified preparations of LOS. Using
Escherichia coli LPS as a positive control and unchallenged
cells as a negative control, we were able to compare the
immunostimulatory properties of LOS purified from wild
type F62 with truncated LOS, purified from the F62ΔlgtA
mutant. Analysis of cell supernatants by ELISA revealed
no significant differences in the production of TNFα over
a dose range, as seen in (Fig. 2A). For subsequent experi-
ments, an initial challenge dose of 10 ng/ml LOS/LPS was
used, as it did not result in significant monocyte cell
death, yet did result in measurable cytokine production.
Measurement of IL-12 similarly revealed no significant
differences between F62 and the truncated mutant, as seen
in (Fig. 2B). Unchallenged samples did not result in meas-
urable cytokine production. IL-10 expression was also
analyzed, but no values above the limit of detection by
ELISA were obtained. While it does appear that gonococ-
cal LOS elicits significantly more TNFα from THP-1 cells
than does E. coli LPS (Fig. 2A) we attribute this to differ-
ences in the molar ratios of the two molecules, when used
at the same concentration.
Challenge with distinct whole-cell gonococcal LOS 
variants elicits similar levels of TNFα and IL-12
We hypothesized that the LOS on whole bacteria may be
presented differently to monocytes than purified LOS. In
order to test this, we challenged THP-1 cells with two var-
iants of live gonococci. IL-12 was measured at 18 hours
after challenge with a range of bacterial doses and levels
were shown to be equal between variants (Fig. 3). Simi-
larly, no difference in TNFα was observed between chal-
lenge phenotypes (Fig. 4). Challenge with whole-cell
bacteria however, did result in greater production of TNFα
when compared with the molar equivalent challenge dose
of LOS. The same trend was evident for IL-12 (data not
shown). Since this observation was likely to have resulted
from growth of the bacteria in vitro, we eliminated this
variable by using gentamicin sulfate to kill the gonococci
prior to challenge. Gentamicin is an aminoglycoside anti-
biotic and binds directly to ribosomal RNA, thereby
inhibiting protein synthesis [32]. Use of this antibiotic
does not cause lysis of the bacteria. Upon staining and vis-
ualization of killed bacteria, the cells appeared as normal
diplococci (data not shown). As shown in figure 5, killed
gonococci elicited less IL-12 than live gonococci at 18 hrs
post challenge. This is likely due to increased concentra-
tions of bacterial surface components due to bacterial
growth. No differences were observed between LOS vari-
ants. To avoid the complication of in vitro gonococcal
growth as well as phase variation, we chose to utilize gen-
tamicin-killed bacteria for the rest of the experiments
described.
Challenge of primary human monocytes with two whole-
cell LOS variants reveals similar elicitation of TNFα, IL-10, 
IL-12, and IL-8
In order to examine the effects of LOS variation in a pri-
mary cell model, we utilized monocytes derived from
human whole blood. These primary cells were challenged
with two variants of gentamicin-killed gonococci,
F62ΔlgtA (as described above) and F62ΔlgtD which
expresses a single LOS component containing the termi-
nal lacto-N-neotetraose structure [9]. Use of these fixed
variants also ensured that no variation of LOS was occur-
ring in vitro. After incubation, sample supernatants were
tested for the presence of TNFα, IL-10, IL-12, and IL-8.
Over the dose range tested, no differences in cytokine pro-
duction were observed when comparing the two variants
(Fig. 6). However, these data demonstrate that gonococci
can elicit all four of these cytokines from human mono-
cytes. In addition, a large amount of the chemokine IL-8
was elicited by gonococci, implying a significant role for
this chemokine during infection by N. gonorrhoeae.
Sialylation of gonococcal LOS does not alter production of 
TNFα or IL-12
Since sialylation of gonococcal LOS is likely to play a role
in natural infection, we examined its effects on monocytic
cytokine production. After growing gonococci in the pres-
ence of CMP-NANA, the bacterial LOS was extracted and
analyzed via polyacrylamide gel electrophoresis. This
process confirmed the efficacy of the sialylation proce-
dure. Figure 7A shows (from left) wild type F62 and the
F62ΔlgtD gonococcal variant expressing only the fixed
lacto-N-neotetraose LOS structure, and sialylated
F62ΔlgtD (grown in the presence of CMP-NANA). A shift
in molecular weight between the F62ΔlgtD and sialylated
F62ΔlgtD samples is indicative of the addition of sialic
acid to the terminal LOS sugar. Figure 7B shows the result
of two challenge experiments utilizing the sialylated
gonococci. There was no significant difference observed in
either IL-12 or TNFα production as a result of challenge
with sialylated bacteria. Therefore sialylation of gonococ-
cal LOS does not appear to play a role in altering host pro-
duction of TNFα or IL-12.
Gonococcal sialylation elicits production of MCP-2
In order to further study whether sialylation of gonococcal
LOS alters monocytic cytokine production, we utilized a
cytokine array (Fig. 8A). This assay allowed simultaneous
measurement of 42 different cytokines. Challenge with
gonococci resulted in upregulation of several cytokines
including: GRO (growth regulated oncogene), IL-1β, IL-6,
IL-10, GM-CSF (granulocyte-macrophage colony stimu-Page 4 of 15
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Production of TNFα and IL-12 by THP-1 cells challenged with purified LOS/LPSFigure 2
Production of TNFα and IL-12 by THP-1 cells challenged with purified LOS/LPS. (A) Sample supernatants were col-
lected 7 hrs after challenge of THP-1 cells (1 × 106/sample). These data are the result of two experiments, each performed in 
triplicate. Error bars indicate the standard deviation of the mean. (B) Sample supernatants were collected 16 hrs after challenge 
of THP-1 cells 1 × 106/sample. These data represent one experiment, performed in triplicate, and the trend is similar to that 
seen from multiple single experiments, each performed at different time points. Error bars indicate the standard deviation of 
the mean. (LPS = E. coli LPS).
BMC Microbiology 2007, 7:7 http://www.biomedcentral.com/1471-2180/7/7lating factor), TNFα, MDC (macrophage-derived chem-
oattractant), and RANTES when compared to samples
challenged with media alone. Several cytokines [IL-8,
MCP-1, and PDGF-B (platelet-derived growth factor-B)]
were also measurable in unchallenged samples. There is a
slight disconnect between cytokines measured in this
assay compared with those measured previously by ELISA.
No IL-12 was measurable during the array experiment and
we attribute this to the different antibody pairs used in
printing the array. In addition, IL-8 did not appear to be
significantly upregulated between unchallenged and chal-
lenged samples since the spots were saturated on both
arrays chosen for analysis. Even upon examination of a
one second exposure, values for the IL-8 spots far
exceeded positive control values. In addition, positive
control values from these early exposures did not fall in
the linear range, and therefore these arrays could not be
included in the statistical analysis (data not shown). How-
ever, previous analysis by ELISA did allow quantitation of
the IL-8 produced during challenge.
Interestingly, challenge with sialylated gonococci caused
production of MCP-2 (monocyte chemoattractant pro-
tein-2) in comparison with unsialylated gonococci (Fig.
8). MCP-2 was not detected in unchallenged samples or
those challenged with unsialylated gonococci. Due to the
limits of this type of assay, we could not determine fold
change in the observed difference in MCP-2 production. A
variety of immune cells are targets for this chemokine and
chemotactic responses have been shown to differ depend-
ing upon the concentration of MCP-2 in vitro. Quantita-
tion of MCP-2 regarding these gonococcal challenge
experiments would allow greater speculation as to its bio-
logical significance [33].
Discussion
Gonococcal LOS is an important surface molecule that
contributes to disease. In this study, we measured the
effect of variation in carbohydrate structure on the pro-
duction of a variety of cytokines by monocytes. The data
demonstrate that alterations in the carbohydrate moiety
Production of IL-12 by THP-1 cells challenged with live gonococcal variants over a dose rangeFigure 3
Production of IL-12 by THP-1 cells challenged with live gonococcal variants over a dose range. Various doses of live gonococci 
were added toTHP-1 cells (1 × 106/ml). At 18 hours post infection, supernatants were collected and analyzed by ELISA. Data 
shown are from one experiment, performed in triplicate. Error bars indicate the standard deviation.Page 6 of 15
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human monocytes. However, whole-cell bacterial chal-
lenge was more stimulatory than challenge with purified
LOS, implying an important role for other surface struc-
tures with regard to cytokine elicitation. Sialylation of
LOS resulted in elicitation of the chemokine MCP-2 from
challenged cells. As the LOS structure associated with
symptomatic infection (lacto-N-neotetraose) is readily
sialylated in vivo, differential elicitation of cytokines due
to sialylation could significantly impact disease progres-
sion by increasing the response of specific immune cell
types.
Several groups have measured cytokine production during
in vitro challenge with N. gonorrhoeae. Because different
models have been employed, the results vary with respect
to which cytokines are produced and in what quantities.
In this study, we observed production of TNFα, IL-12, IL-
10, and IL-8 by monocytes in response to whole-cell
gonococcal challenge as well as in response to challenge
with purified LOS. Intact gonococci elicited a much
greater response than purified LOS/LPS. Since these exper-
iments were performed, this observation has been con-
firmed by several groups studying N. meningitidis. It has
been demonstrated that N. meningitidis deficient in detect-
able LOS (LpxA-) induces substantial cytokine production
from human peripheral blood mononuclear cells when
compared to wild type bacteria [34,35]. Similarly, intact
meningococci have been shown to be more potent induc-
ers of several cytokines than equal amounts of purified
LPS [34]. In contrast, Unkmeir, et al. reported that chal-
lenge of dendritic cells with an N. meningitidis strain lack-
ing LOS resulted in almost undetectable levels of TNFα,
IL-6, and IL-8 [36]. However, this difference may be
related to the use of dendritic cells as a model. These data,
along with our observations, indicate that a substantial
portion of the cytokines elicited from gonococcal interac-
tions with monocytes, result from non-LPS components.
During these experiments we observed no difference in
the elicitation of TNFα, IL-10, IL-12, or IL-8 between
gonococcal LOS variants. Based on these observations, we
believe that while the carbohydrate portion of the LOS
molecule is important for pathogenesis of the organism, it
does not play a significant role in determining host
cytokine profile during gonococcal encounters with
monocytes. Pridmore, et al. challenged THP-1 cells with
purified LOS (200 ng) from different neisserial strains and
measured TNFα production and signaling through TLR4/
MD2 [35]. Some variability was observed, although this
did not correspond with oligosaccharide structure of the
strains. Braun, et al. demonstrated that N. meningitidis var-
iants expressing LOS immunotypes isolated from diseased
patients induced significantly higher levels of TNFα and
IL-6 when compared with immunotypes primarily associ-
ated with carriers of the bacteria [37]. However, the
immunotypes that differed in their ability to induce
cytokine production each expressed identical oligosaccha-
ride moieties. Interestingly, disruption of the lpxLII gene
in N. gonorrhoeae was shown to alter the lipid A backbone
of the LOS molecule, resulting in mutants with a reduced
ability to induce TNFα, IL-1β, IL-6, and IL-8 from a
human macrophage model [38].
Taken together, these data imply that differences in the
immunostimulatory potential of gonococcal LOS variants
during interactions with human monocytes originate
from alterations in the lipid A structure. This hypothesis is
supported by the fact that acylation patterns of the lipid A
portion of meningococcal LOS have been demonstrated
to be important in determining levels of TNFα elicited
from a human macrophage cell line [39].
It has been previously shown that when dendritic cells are
challenged with N. meningitidis, optimal production of
TNFα and Il-12 only occurs upon internalization of the
bacteria [27]. In addition, this internalization appeared to
be dependent on expression of LOS, as an LOS-deficient
mutant was internalized poorly compared to wild type
bacteria. In future studies, it would be interesting to study
the effects of gonococcal oligosaccharide alterations dur-
ing interactions with other cellular models, such as den-
dritic cells. In addition, measurement of internalization,
Comparison of TNFα production upon challenge with live gonococci vs. challenge with purified LOSFigure 4
Comparison of TNFα production upon challenge with live 
gonococci vs. challenge with purified LOS. THP-1 cells (1 × 
106/ml) were challenged with either 1 × 105/ml live gono-
cocci or a molar equivalent amount of LOS/LPS (10 ng/ml). 
At three hours post challenge, sample supernatants were 
analyzed for TNFα by ELISA. These data represent two 
experiments, each performed in triplicate. Error bars indi-
cate the standard deviation. (Rc LPS was purified from a 
rough LPS E. coli variant.)Page 7 of 15
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macrophages with gonococcal lipid A mutants, may pro-
vide significant insight into gonococcal pathogenesis.
Data collected from these experiments allowed a broad
look at the cytokine profile of monocytes after gonococcal
challenge. A variety of cytokines and chemokines were
measurable during infection including: GRO, IL-1β, IL-6,
IL-10, IL-12, GM-CSF, TNFα, MDC, and IL-8. The cytokine
profile we observed differed slightly from that observed
by Makepeace, et al., who utilized a differentiated human
macrophage model during gonococcal challenge studies
[40] Though production of several cytokines [including
TNFα, IL-6, macrophage inflammatory protein-1-alpha
(MIP-1α), and RANTES] was measured, no secretion of IL-
1β, epithelial neutrophil-activating protein 78 (ENA-78),
GM-CSF, IL-10, or IL-12 was reported. Since we were able
to measure IL-1β, GM-CSF, IL-10 and IL-12 during chal-
lenge, it is possible that use of differentiated cells, a differ-
ent gonococcal strain (P9), and a higher infectious dose
(MOI = 400) by this group explains these differences with
regard to our own observations. Further analysis of the
roles of the cytokines and chemokines measured in this
study could significantly contribute to our understanding
of gonococcal disease.
Sialylation of gonococcal LOS has been previously shown
to convert serum sensitive strains to a serum resistant phe-
notype [41,42]. However, sialylation has also been shown
to play a role in other aspects of gonococcal pathogenesis
including interactions with antibodies and phagocytes
(for review see [43]). In these studies, sialylation of gono-
coccal LOS prior to challenge of THP-1 cells resulted in
similar production of TNFα or IL-12. These experiments
were followed by use of an array to examine cytokine pro-
duction from challenged primary monocytes. This work
demonstrated that sialylated gonococcal challenge sam-
ples exhibited upregulation of monocyte chemoattractant
protein-2 (MCP-2), in comparison to unchallenged sam-
ples and those challenged with unsialylated bacteria.
MCP-2 is a low molecular weight monocyte chemotactic
cytokine which is closely related to MCP-1 and monocyte
chemoattractant protein-3 (MCP-3) [33]. Target cells for
MCP-2 include monocytes, T lymphocytes, natural killer
cells, eosinophils, and basophils, though monocytes are
the most sensitive. The concentration of MCP-2 present in
vitro has been shown to differentially activate specific tar-
get cell populations[33]. While MCP-2 production in
response to gonococcal infection was seen in a human
mononuclear cell model, gonococci were not sialylated
prior to challenge [44]. As LOS molecules associated with
Production of IL-12 upon challenge with live vs. gentamicin-killed gonococciFigure 5
Production of IL-12 upon challenge with live vs. gentamicin-killed gonococci. THP-1 cells (1 × 106/ml) were chal-
lenged with either 1 × 105/ml live or gentamicin-killed gonococci. At 18 hrs post challenge, IL-12 was measured by ELISA. 
These data represent one experiment, performed in triplicate. Error bars indicate the standard deviation.Page 8 of 15
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readily sialylated in vivo, production of MCP-2 during
infection may substantially increase the response of a spe-
cific cellular population during gonococcal infection.
Future determination as to the quantities of MCP-2 pro-
duced during monocyte interactions with sialylated gono-
cocci may provide insight into the pathogenesis of these
more virulent strains. In addition, further analysis of the
mechanism by which sialylated LOS causes production of
MCP-2 may significantly add to our knowledge of the
pathogenesis of N. gonorrhoeae.
Conclusion
In order to analyze the impact of antigenic variation in
gonococcal LOS, we utilized gonococcal mutants with
specific LOS structures to challenge human monocytes.
These mutants expressed LOS structures associated with
either symptomatic (F62/F62ΔlgtD) or asymptomatic
(F62ΔlgtA) infection. These specific LOS structures have
been previously shown to affect gonococcal interaction
with epithelial cell models [9]. Upon challenge of mono-
cytes during this study, the levels of several proinflamma-
tory cytokines were measured. The data generated
Production of TNFα, IL-10, IL-12, and IL-8 upon challenge of primary human monocytesFigure 6
Production of TNFα, IL-10, IL-12, and IL-8 upon challenge of primary human monocytes. Monocytes were iso-
lated from human whole blood and cells (1 × 106/ml) were challenged with varying doses of gentamicin-killed gonococci. Sam-
ple supernatants were collected at 18 hrs post challenge and cytokines were analyzed by ELISA. Clear bars indicate challenge 
with F62ΔlgtD and shaded bars indicate challenge with F62ΔlgtA Challenge with media alone resulted in no measurable TNFα 
or IL-10 and less than 100 pg/ml IL-12; Approximately 1 ng/ml IL-8 was measurable from negative controls, with a standard 
error of 0.8 ng/ml. (A) TNFα (B) IL-10 (C) IL-8 (D) IL-12 These data represent three experiments, each performed in tripli-
cate. Error bars indicate the standard error of the mean.Page 9 of 15
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of LOS do not directly impact the production of these
cytokines. From our data, as well as several other reports,
it seems likely that differences in the immunostimulatory
potential of LOS variants during interactions with human
monocytes may stem from alterations in the structure of
lipid A [35,37-39]. In addition, whole-cell bacterial chal-
lenge was shown to be much more stimulatory than chal-
lenge with purified LOS. This implies that other surface
structures may play an important role with regard to
cytokine elicitation. Sialylation of LOS was shown to
result in upregulation of the chemokine MCP-2 from chal-
lenged cells. As MCP-2 is associated with recruitment of
monocytes, this finding may indicate a role for sialylation
during further interactions with this cell type. A greater
understanding of the mechanism behind MCP-2 elicita-
tion by gonococci, as well as quantitation of this cytokine
during challenge, will be important questions to explore
in the future.
Methods
Bacterial strains and infection
Gonococcal strain F62 was obtained from Dr. P. Frederick
Sparling (University of North Carolina, Chapel Hill, NC).
Production of TNFα and IL-12 upon challenge with gonococci expressing sialylated LOSFigure 7
Production of TNFα and IL-12 upon challenge with gonococci expressing sialylated LOS. Bacterial LOS was ana-
lyzed via polyacrylamide gel electrophoresis. (A) LOS samples shown (from left): wild type F62, F62ΔlgtD, and F62ΔlgtD grown 
in the presence of CMP-NANA (sialylated). (B) THP-1 cells (1 × 106/ml) were challenged with sialylated and unsialylated N. gon-
orrhoeae. Cytokine production in sample supernatants was measured by ELISA. Left panel: IL-12 levels after an 18 hour chal-
lenge of THP-1 cells (1 × 106/ml) with 1 × 102/ml live N. gonorrhoeae. Right panel: TNFα levels after 7 hour challenge of THP-1 
cells (1 × 106/ml) with 1 × 108 gentamicin-killed gonococci. (S) Represents sialylated samples (grown in the presence of CMP-
NANA). Challenge with media alone did not result in measurable production of IL-12 or TNFα.Page 10 of 15
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Comparison of MCP-2 production upon challenge with either F62ΔlgtD or sialylated F62ΔlgtDFigure 8
Comparison of MCP-2 production upon challenge with either F62ΔlgtD or sialylated F62ΔlgtD. Primary human 
monocytes (1 × 106/ml) were challenged with gentamicin-killed gonococci (1 × 107/ml) for 18 hours prior to analysis of sample 
supernatants using a protein array to detect the presence of cytokines. Densitometric analysis was carried out using a Gel Doc 
2000 camera and Quantity One Software (BioRad Laboratories, Inc.). Analysis of internal positive controls (+) among array 
exposures using a paired, two-tailed, t test with a 95% confidence interval indicated that the means were statistically similar (P 
> 0.05), allowing cross comparison of sample cytokine levels. (A) Whole array for each sample: (-) negative control, F62ΔlgtD, 
and F62ΔlgtD (S) Dashed boxes indicate the location of MCP-2 antibodies spotted on the array membrane. (B) Internal posi-
tive controls compared with MCP-2. Data shown are from one experiment. (S) Indicates sialylated samples.
BMC Microbiology 2007, 7:7 http://www.biomedcentral.com/1471-2180/7/7F62ΔlgtD, a derivative of F62 that expresses a non-varying
LOS, lacto-N-neotetraose, and F62ΔlgtA, a derivative of
F62, expresses a fixed lactosyl LOS structure and has been
previously described [9]. Prior to each experimental chal-
lenge, gonococci were grown on GCK agar and piliated,
Opa- organisms were selected. (Initial studies indicated
that non-piliated gonococci elicited a similar cytokine
profile compared with piliated gonococci, regarding
measurement of TNFα, IL-8, IL-12, and IL-10.) Bacteria
were suspended in GCP broth supplemented with Kel-
logg's solution [45], the concentration of cells was deter-
mined spectrophotometrically and verified via viable
plate count. Cells were killed by incubation for three
hours with 2 mg/ml gentamicin sulfate. Bacteria were
stored at 4°C until challenge of human cells. Prior to bac-
terial challenge, gentamicin-killed bacteria were collected
by centrifugation (12,000 rpm for 5 min.), resuspended in
RPMI 1640 (Mediatech, Herndon, VA), and diluted as
needed. Use of killed bacteria prevented growth and
phase variation during the incubation period. For experi-
ments involving E. coli, either strain DH5-α was used
(New England Biolabs, Ipswich, MA) or an Rc strain of E.
coli (E. coli Genetic Stock Center) as indicated. For experi-
ments using LPS as a negative control, LPS was obtained
from Sigma Chemical Co. (St. Louis, MO).
LOS extraction procedure for monocyte challenges
Purified LOS was obtained from broth grown cells
through the hot-phenol method followed by lyophiliza-
tion [46]. Repeated phenol water extractions/lyophiliza-
tions were performed until an aliquot of purified LOS
dissolved in water at a concentration of 1 mg/ml gave no
detectable absorbance, when measured spectrophotomet-
rically at A280. Molar equivalencies were determined by
weighing purified LOS, and analyzing dilutions of these
samples along with dilutions of LOS prepared using the
quick prep procedure via SDS-PAGE. Gels were silver
stained, and the intensity of bands obtained with purified
LOS were compared to the intensity of bands obtained
from quick preps. This allowed us to determine that
approximately 10 ng LOS was equivalent to 1 × 105 gono-
cocci.
LOS extraction procedure for SDS-PAGE analysis
After sialylation, quick preparations of gonococcal LOS
were prepared from bacterial suspensions using the
method of Hitchcock and Brown [47]. An aliquot of 1 ml
(approximately 1 × 109 bacteria/ml) was centrifuged at
10,000 rpm and the pellet was re-suspended in 50 μl lys-
ing solution [1 M Tris-HCl (pH = 6.8), 2% SDS, 4% 2-
mercaptoethanol, 10% glycerol, bromophenol blue to
saturation]. Proteinase K (10 μl of 1 mg/ml stock) was
added and the sample was incubated at 60°C for one
hour. Samples were then diluted 1:25 in lysing solution.
Prior to SDS-PAGE analysis, samples were boiled for 10
min and 5 μl was loaded onto the gel.
Gonococcal LOS sialylation
Prior to challenge using sialylated bacteria, gonococci
were grown on GCK agar and piliated, Opa- organisms
were selected. Bacteria were suspended in GCP broth sup-
plemented with Kellogg's solution [45]. Cells were col-
lected from plates using sterile swabs and resuspended in
PBS to a Klett reading of 40. The concentration of cells was
determined spectrophotometrically and verified via viable
plate count. CMP-NANA was added to the bacterial sus-
pension at a concentration of 50 μg/ml. Bacteria were
incubated for 4 hrs, in a 37°C rolling incubator. After
incubation, the concentration of bacteria was verified by
viable plate count. Bacterial sialylation was verified by
LOS extraction and SDS-PAGE analysis (as described
above).
Cell lines
THP-1 (human, peripheral blood, leukemia, acute mono-
cytic) cells used were originally from the American Type
Culture Collection (Manassas, VA) and were donated to
our laboratory courtesy of Dr. David Mosser. Cells were
grown in RPMI 1640 with 10% fetal bovine serum
(Sigma-Aldrich Chemical Co, St. Louis, Mo) and 2 mM L-
glutamine, supplemented with 0.05 mM 2-mercaptoetha-
nol. FBS contained less than 10 EU/ml endotoxins, as
measured by USP gel clot assay done by the commercial
provider. Fresh medium was added every 2–3 days or
when cell concentrations exceeded 8 × 105 cells/ml. Prior
to experimentation, cell numbers were enumerated using
a hemocytometer and plated at a concentration of 1 × 106
per ml.
Isolation and culture of human monocytes/macrophages
Whole blood was drawn from healthy volunteers and
peripheral blood mononuclear cells were prepared by
density gradient centrifugation using Ficoll-Paque Plus.
Briefly, blood was collected in heparinized tubes (BD Bio-
sciences, San Jose, CA) and transferred to 50 ml conical
tubes. The volume in each tube was brought to approxi-
mately 36 ml using warm PBS and cells were gently
pipeted to ensure mixing. 14 ml of Ficoll-Paque Plus
(Amersham Biosciences, Piscataway, NJ) was added
beneath the blood suspension. (When necessary an
untreated tube was used to collect blood for serum.) All
blood tubes were centrifuged for 20 min at room temper-
ature (RT), at 2500 rpm, and with the brake set to zero.
This step was followed by transfer of the opaque layer
(containing peripheral blood mononuclear cells) to a new
50 ml conical tube and dilution of the cells 1:1 with RPMI
1640 or removal of the serum layer into a separate tube.
(Serum was heat inactivated for 25 min at 56°C prior to
use in sample media.) Cells were centrifuged for 10 minPage 12 of 15
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volume of RPMI 1640, transferred to a 15 ml conical tube,
and centrifuged for 10 minutes at 4°C, at 2500 rpm.
Supernatants were aspirated and cells counted on a hemo-
cytometer. Prior to bacterial challenges, cells were seeded
at 1 × 106 cells/ml in tissue culture-treated plates in RPMI
1640 and incubated at 37°C, 5% CO2 with humidity.
After 30 min, the cells were washed to remove the nonad-
herent population and RPMI 1640 (supplemented with
10% autologous heat-inactivated serum) was added pre-
ceding bacterial challenge.
All studies employing human blood were approved by the
University of Maryland's Institutional Review Board (IRB
#01321, "Immune Response to Gonococcal Infection")
prior to the initiation of any of these experiments.
ELISA
Prior to bacterial challenge, primary human monocytes
were isolated and seeded as described above. Following
challenge with the appropriate dilution (100 μl) of gen-
tamicin-killed gonococci, cells were incubated in RPMI
1640 supplemented with 10 % autologous human serum
at 37°C 5 % CO2 with humidity for the time specified.
Cell supernatants were collected and assayed for the pres-
ence of cytokines by sandwich ELISA. Upon collection of
supernatants, a protease inhibitor cocktail was added and
each sample was stored at -80°C until analysis. Antibody
pairs and recombinant standards for human TNFα, IL-8,
IL-10, and IL-12p40 were purchased from BD Pharmin-
gen (San Diego, CA). Antibody pairs, recombinant stand-
ards, and neutralizing antibody for human IL-1β were
purchased from R&D Systems (Minneapolis, MN). ELISAs
were carried out according to protocols provided by BD
Pharmingen. Streptavidin alkaline phosphatase and p-
nitrophenyl phosphate substrate were purchased from
Southern Biotech (Birmingham, AL) and used according
to the manufacturer's specifications. Samples were read at
405 nm in 96-well, untreated, flat-bottom plates.
Cytokine array
Primary human monocytes were isolated as described
above and seeded into 24-well tissue culture plates at 1 ×
106 cells/ml. The appropriate dilution (100 μl) of gen-
tamicin-killed gonococci was added to each sample mon-
olayer, and cells were incubated in RPMI 1640
supplemented with 10 % autologous human serum at
37°C, 5 % CO2 with humidity for 18 hrs. Supernatants
from quadruplicate samples were pooled before addition
to the array membrane. The RayBio Human Cytokine
Array III was purchased from Raybiotech, Inc. (Norcross,
GA) and used according to manufacturer's instructions.
Array membranes were analyzed using a Gel Doc camera
and Quantity One software (Bio-Rad Laboratories, Inc.,
Hercules, CA). The volume array tool (for 96 wells) was
used to specify area intensity for each spot within an
image. A "background" volume was placed over the inter-
nal negative control for each array. The average intensity
of pixels in this volume was calculated and subtracted
from each pixel in all other volumes. This process resulted
in calculation of the "adjusted volume" (i.e. spot intensity
minus the average intensity of the internal negative con-
trol). Positive controls from several exposures were com-
pared and the means were found to be statistically similar
(P > 0.05) using a paired, two-tailed, t test with a 95%
confidence interval, thus allowing cross comparison of
sample cytokine levels. Adjusted volumes (two for each
cytokine) were then averaged and the standard deviation
was determined.




ENA-78 epithelial neutrophil-activating protein 78
GM-CSF granulocyte-macrophage colony stimulating fac-
tor









MCP-1 monocyte chemoattractant protein-1
MCP-2 monocyte chemoattractant protein-2
MCP-3 monocyte chemoattractant protein-3
MDC macrophage-derived chemoattractant
MIP-1α macrophage inflammatory protein-1-alpha
Opa opacity-associated proteinPage 13 of 15
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PID pelvic inflammatory disease
RANTES regulated upon activation, normal T-cell
expressed, and presumably secreted
TNFα tumor necrosis factor alpha
Authors' contributions
JP performed all of the experimental manipulations
described in this manuscript. DS conceived of the study,
and participated in its design and coordination. All
authors read and approved the final manuscript.
Acknowledgements
This work was supported by a grant from the National Institutes of Health, 
AI24452, to DCS.
References
1. Edwards JL, Apicella MA: The molecular mechanisms used by
Neisseria gonorrhoeae to initiate infection differ between
men and women.  Clin Microbiol Rev 2004, 17:965-981s.
2. Gronow S, Brade H: Lipopolysaccharide biosynthesis: which
steps do bacteria need to survive?  J Endotoxin Res 2001, 7:3-23.
3. Martich GD, Boujoukos AJ, Suffredini AF: Response of man to
endotoxin.  Immunobiol 1993, 187:403-416.
4. Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF:
Gram-negative endotoxin: an extraordinary lipid with pro-
found effects on eukaryotic signal transduction.  Faseb J 1991,
5:2652-2660.
5. Griffiss JM, Schneider H, Mandrell RE, Yamasaki R, Jarvis GA, Kim JJ,
Gibson BW, Hamadeh R, Apicella MA: Lipooligosaccharides: the
principal glycolipids of the neisserial outer membrane.  Rev
Infect Dis 1988, 10:S287-295.
6. Danaher RJ, Levin JC, Arking D, Burch CL, Sandlin R, Stein DC:
Genetic basis of Neisseria gonorrhoeae lipooligosaccharide
antigenic variation.  J Bacteriol 1995, 177:7275-7279.
7. Apicella MA, Shero M, Jarvis GA, Griffiss JM, Mandrell RE, Schneider
H: Phenotypic variation in epitope expression of the Neisse-
ria gonorrhoeae lipooligosaccharide.  Infect Immun 1987,
55:1755-1761.
8. Schneider H, Griffiss JM, Boslego JW, Hitchcock PJ, McJunkin KO,
Apicella MA: Expression of paragloboside-like lipooligosaccha-
ride may be a necessary component of gonococcal pathogen-
esis in men.  J Exp Med 1991, 174:1601-1605.
9. Song W, Ma L, Chen W, Stein DC: Role of lipooligosaccharide in
opa-independent  invasion of Neisseria gonorrhoeae into
human epithelial cells.  J Exp Med 2000, 191:949-959.
10. Harvey HA, Jennings MP, Campbell CA, Williams R, Apicella MA:
Receptor-mediated endocytosis of Neisseria gonorrhoeae
into primary human urethral epithelial cells: the role of the
asialoglycoprotein receptor.  Mol Microbiol 2001, 42:659-672.
11. Harvey HA, Swords WE, Apicella MA: The mimicry of human gly-
colipids and glycosphingolipids by the lipooligosaccharides of
pathogenic neisseria and haemophilus.  J Autoimmun 2001,
16:257-262.
12. Smith H, Parsons NJ, Cole JA: Sialylation of neisserial lipopoly-
saccharides: a major influence on pathogenicity.  Mircob Path
1995, 19:365-377.
13. Wetzler LM, Barry K, Blake MS, Gotschlich EC: Gonococcal lipoo-
ligosaccharide sialylation prevents complement-dependent
killing by immune sera.  Infect Immun 1992, 60:39-43.
14. Rest RF, Frangipane JV: Growth of Neisseria gonorrhoeae in
CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-
associated outer membrane protein-mediated) interactions
with human neutrophils.  Infect Immun 1992, 60:989-997.
15. Kim JJ, Zhou D, Mandrell RE, Griffiss JM: Effect of exogenous sia-
lylation of the lipooligosaccharides of Neisseria gonorrhoeae
on opsonophagocytosis.  Infect Immun 1992, 60:4439-4442.
16. van Putten JP, Grassme HU, Robertson BD, Schwan ET: Function of
lipopolysaccharide in the invasion of Neisseria gonorrhoeae
into human mucosal cells.  Prog Clin Biol Res 1995, 392:49-58.
17. Alexander C, Rietschel ET: Bacterial lipopolysaccharides and
innate immunity.  J Endotox Res 2001, 7:167-202.
18. McGee ZA, Jensen RL, Clemens CM, Taylor-Robinson D, Johnson AP,
Gregg CR: Gonococcal infection of human fallopian tube
mucosa in organ culture: relationship of mucosal tissue TNF-
alpha concentration to sloughing of ciliated cells.  Sex Transm
Dis 1999, 26:160-165.
19. McGee ZA, Clemens CM, Jensen RL, Klein JJ, Barley LR, Gorby GL:
Local induction of tumor necrosis factor as a molecular
mechanism of mucosal damage by gonococci.  Microb Pathog
1992, 12:333-341.
20. Morales P, Reyes P, Vargas M, Rios M, Imarai M, Cardenas H, Crox-
atto H, Orihuela P, Vargas R, Fuhrer J, Heckels JE, Christodoulides M,
Velasquez L: Infection of human fallopian tube epithelial cells
with Neisseria gonorrhoeae protects cells from tumor
necrosis factor alpha-induced apoptosis.  Infect Immun 2006,
74:3643-3650.
21. Patrone JB, Bish SE, Stein DC: TNF-alpha-independent IL-8
expression: alterations in bacterial challenge dose cause dif-
ferential human monocytic cytokine response.  J Immunol
2006, 177:1314-1322.
22. Ramsey KH, Schneider H, Cross AS, Boslego JW, Hoover DL, Staley
TL, Kuschner RA, Deal CD: Inflammatory cytokines produced
in response to experimental human gonorrhea.  J Infect Dis
1995, 172:186-191.
23. Naumann M, Wessler S, Meyer TF: Neisseria gonorrhoeae epi-
thelial cell interaction leads to the activation of the tran-
scription factors nuclear factor kappaB and activator protein
1 and the induction of inflammatory cytokines.  J Exp Med
1997, 186:247-258.
24. Harvey HA, Post DM, Apicella MA: Immortalization of human
urethral epithelial cells: a model for the study of the patho-
genesis of and the inflammatory cytokine response to Neis-
seria gonorrhoeae infection.  Infect Immun 2002, 70:5808-5815.
25. Fichorova RN, Desai PJ, Gibson FC 3rd, Genco CA: Distinct proin-
flammatory host responses to Neisseria gonorrhoeae infec-
tion in immortalized human cervical and vaginal epithelial
cells.  Infect Immun 2001, 69:5840-5848.
26. Anzala AO, Simonsen JN, Kimani J, Ball TB, Nagelkerke NJ, Ruther-
ford J, Ngugi EN, Bwayo JJ, Plummer FA: Acute sexually transmit-
ted infections increase human immunodeficiency virus type
1 plasma viremia, increase plasma type 2 cytokines, and
decrease CD4 cell counts.  J Infect Dis 2000, 182:459-466.
27. Uronen-Hansson H, Steeghs L, Allen J, Dixon GL, Osman M, van der
Ley P, Wong SY, Callard R, Klein N: Human dendritic cell activa-
tion by Neisseria meningitidis: phagocytosis depends on
expression of lipooligosaccharide (LOS) by the bacteria and
is required for optimal cytokine production.  Cell Microbiol
2004, 6:625-637.
28. Zughaier S, Agrawal S, Stephens DS, Pulendran B: Hexa-acylation
and KDO(2)-glycosylation determine the specific immunos-
timulatory activity of Neisseria meningitidis lipid A for
human monocyte derived dendritic cells.  Vaccine 2006,
24:1291-1297.
29. Zughaier SM, Tzeng YL, Zimmer SM, Datta A, Carlson RW, Stephens
DS: Neisseria meningitidis lipooligosaccharide structure-
dependent activation of the macrophage CD14/Toll-like
receptor 4 pathway.  Infect Immun 2004, 72:371-380.
30. Brandtzaeg P, Bryn K, Kierulf P, Ovstebo R, Namork E, Aase B,
Jantzen E: Meningococcal endotoxin in lethal septic shock
plasma studied by gas chromatography, mass-spectrometry,
ultracentrifugation, and electron microscopy.  J Clin Invest
1992, 89:816-823.
31. Melly MA, McGee ZA, Rosenthal RS: Ability of monomeric pepti-
doglycan fragments from Neisseria gonorrhoeae to damage
human fallopian-tube mucosa.  J Infect Dis 1984, 149:378-386.
32. Yoshizawa S, Fourmy D, Puglisi JD: Structural origins of gen-
tamicin antibiotic action.  Embo J 1998, 17:6437-6448.Page 14 of 15
(page number not for citation purposes)
BMC Microbiology 2007, 7:7 http://www.biomedcentral.com/1471-2180/7/7Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
33. Proost P, Wuyts A, Van Damme J: Human monocyte chemotac-
tic proteins-2 and -3: structural and functional comparison
with MCP-1.  J Leukoc Biol 1996, 59:67-74.
34. Sprong T, Stikkelbroeck N, van der Ley P, Steeghs L, van Alphen L,
Klein N, Netea MG, van der Meer JW, van Deuren M: Contribu-
tions of Neisseria meningitidis LPS and non-LPS to proin-
flammatory cytokine response.  J Leukoc Biol 2001, 70:283-288.
35. Pridmore AC, Jarvis GA, John CM, Jack DL, Dower SK, Read RC:
Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by
Neisseria is independent of capsule and lipooligosaccharide
(LOS) sialylation but varies widely among LOS from differ-
ent strains.  Infect Immun 2003, 71:3901-3908.
36. Unkmeir A, Kammerer U, Stade A, Hubner C, Haller S, Kolb-Maurer
A, Frosch M, Dietrich G: Lipooligosaccharide and polysaccha-
ride capsule: virulence factors of Neisseria meningitidis that
determine meningococcal interaction with human dendritic
cells.  Infect Immun 2002, 70:2454-2462.
37. Braun JM, Blackwell CC, Poxton IR, Ahmer OE, Gordon AE, Madani
OM, Weir DM, Giersen S, Beuth J: Proinflammatory responses
to lipo-oligosaccharide of Neisseria meningitidis immuno-
type strains in relation to virulence and disease.  J Infect Dis
2002, 185:1431-1438.
38. Ellis CD, Lindner B, Anjam Khan CM, Zahringer U, Demarco de Hor-
maeche R: The Neisseria gonorrhoeae lpxLII gene encodes for
a late-functioning lauroyl acyl transferase, and a null muta-
tion within the gene has a significant effect on the induction
of acute inflammatory responses.  Mol Microbiol 2001,
42:167-181.
39. van der Ley P, Steeghs L, Hamstra HJ, ten Hove J, Zomer B, van
Alphen L: Modification of lipid A biosynthesis in Neisseria
meningitidis lpxL mutants: influence on lipopolysaccharide
structure, toxicity, and adjuvant activity.  Infect Immun 2001,
69:5981-5990.
40. Makepeace BL, Watt PJ, Heckels JE, Christodoulides M: Interactions
of Neisseria gonorrhoeae with mature human macrophage
opacity proteins influence production of proinflammatory
cytokines.  Infect Immun 2001, 69:1909-1913.
41. Nairn CA, Cole JA, Patel PV, Parsons NJ, Fox JE, Smith H: Cytidine
5'-monophospho-N-acetylneuraminic acid or a related com-
pound is the low Mr factor from human red blood cells which
induces gonococcal resistance to killing by human serum.  J
Gen Microbiol 1988, 134:3295-3306.
42. Parsons NJ, Constantinidou C, Cole JA, Smith H: Sialylation of
lipopolysaccharide by CMP-NANA in viable gonococci is
enhanced by low Mr material released from blood cell
extracts but not by some UDP sugars.  Microb Pathog 1994,
16:413-421.
43. Smith H, Parsons NJ, Cole JA: Sialylation of neisserial lipopoly-
saccharide: a major influence on pathogenicity.  Microb Pathog
1995, 19:365-377.
44. Rarick M, McPheeters C, Bright S, Navis A, Skefos J, Sebastiani P,
Montano M: Evidence for cross-regulated cytokine response in
human peripheral blood mononuclear cells exposed to
whole gonococcal bacteria in vitro.  Microb Pathog 2006,
40:261-270.
45. Kellogg DS, Peacock WL, Deacon WE, Brown L, Pirkle CI: Neisseria
gonorrhoeae I. Virulence genetically linked to clonal varia-
tion.  J Bacteriol 1963, 85:1274-1279.
46. Westphal O, Jann K: Bacterial lipopolysaccharides: extraction
with phenol-water and further applications of the procedure.
Meth Carbohydr Chem 1965, 5:83-91.
47. Hitchcock PJ, Brown TM: Morphological heterogeneity among
Salmonella lipopolysaccharide chemotypes in silver stained
polyacrylamide gels.  J Bacteriol 1983, 154:269-277.
48. Tong Y, Arking D, Ye S, Reinhold B, Reinhold V, Stein DC: Neisseria
gonorrhoeae strain PID2 simultaneously expresses six
chemically related lipooligosaccharide structures.  Glycobiol
2002, 12:523-533.Page 15 of 15
(page number not for citation purposes)
